Rheumatologic manifestations of renal disease.
The rheumatologic manifestations of renal disease are commonly encountered and include crystal deposition disease and renal osteodystrophy. In addition, renal transplantation carries important rheumatologic manifestations. Basic calcium phosphate crystal deposition remains an important source of morbidity in renal disease, but it can be largely prevented. Early preventive measures and use of biochemical markers for assessment allow effective management of renal osteodystrophy. Effective treatment is available for the acute bone pain syndrome seen after transplantation, and the natural history of osteonecrosis in such patients may be more benign than previously considered, thus affecting current management schemes for this complication.
Ferrari
R
R
Rheumatic Disease Unit, University of Alberta, Edmonton, Canada.
D002130:Calcium Phosphates / Q000378:metabolism; D002131:Calcium Pyrophosphate / Q000378:metabolism; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000150:complications; D003460:Crystallization; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000378:metabolism; D016030:Kidney Transplantation; D011183:Postoperative Complications; D012216:Rheumatic Diseases / Q000209:etiology*; D014527:Uric Acid / Q000378:metabolism
D002130:Calcium Phosphates; C485828:alpha-tricalcium phosphate; C485830:tetracalcium phosphate; D014527:Uric Acid; C485838:calcium phosphate, monobasic, anhydrous; C020243:calcium phosphate; C485829:calcium phosphate, dibasic, anhydrous; D002131:Calcium Pyrophosphate